CCAAT/enhancer-binding protein δ: A molecular target of 1,25-dihydroxyvitamin D 3 in androgen-responsive prostate cancer LNCaP cells

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4762-4768

  Ikezoe, Takayuki ^a,b   Gery, Sigal ^a   Yin, Dong ^a   O'Kelly, James ^a   Binderup, Lise ^c   Lemp, Nathan ^a   Taguchi, Hirokuni ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN DELTA; ESTROGEN RECEPTOR;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; DRUG TARGETING; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE; TISSUE MICROARRAY; UPREGULATION;

ANDROGENS; BREAST NEOPLASMS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 19644365071     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3619     Document Type: Article

References (41)

1. 3 receptors: gene regulation and genetic circuitry. FASEB J 1988;2:3043-53.
2. 3 on primary cultures of human prostatic cells. Cancer Res 1994;54:805-10.
3. 3. Endocrinology 1995;136:20-6.
4. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB. Development and characterization of non-tumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 1994;54:3413-21.
5. 3 analogs and their 24-oxo metabolites equally Inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. J Cell Biochem 1997;66: 413-25.
6. 3 metabolites. Cancer Res 1983;43:4443-7.
7. Bower M, Colston KW, Stein RC, et al. Topical calcipotriol treatment in advanced breast cancer, Lancet 1991;337:701-2.
8. 3 prolongs survival time of leukemic mice. Proc Natl Acad Sci U S A 1990;87:3929-32.
9. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption, Cancer Res 1990;50:6857-64.
10. 1 accumulation. Endocrinology 1998;139:1197-207.
11. Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Calcitriol-induced apoptosis In LNCaP cells Is blocked by overexpression of Bcl-2. Endocrinology 2000;141: 10-7.
12. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998;273:28545-8.
13. Hurst HC. Transcription factors. 1. bZIP proteins. Protein Profile 1994;1:123-68.
14. Lamb P, McKnight SL. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci 1991;16:417-22.
15. Cao Z, Umek RM, McKnight SL, Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991;5:1538-52.
16. Park DJ, Chumakov AM, Vuong PT, et al. CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment J Clin Invest 1999;103:1399-408.
17. Yamanaka R, Barlow C, Lekstrom-Himes J, et al. Impaired granulopoiesis, myelodysplasla, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A 1997;94: 13187-92.
18. Gery S, Gombart AF, Fung YK, Koeffler HP. C/EBPε Interacts with Retinoblastoma and E2F1 during granulopoiesis. Blood 2004;103:828-35.
19. Flodby P, Barlow C, Kylefjord H, Ahrlund-Richter L, Xanthopoulos KG. Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J Biol Chem 1996;271: 24753-60.
20. Pabst T, Mueller BU Zhang P, et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat Genet 2001;27:263-70.
21. Gombart AF, Hofmann WK, Kawano S, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002; 99:1332-40.
22. Halmos B, Huettner CS, Kocher O, Ferenczi K, Karp DD, Tenen DG. Down-regulation and antiproliferative role of C/EBPα in lung cancer. Cancer Res 2002;62: 528-34.
23. Hutt JA, DeWille JW. Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein δ-dependent pathway. Mol Cancer Ther 2002;1:601-10.
24. 0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland. J Biol Chem 2002; 275:29123-31.
25. O'Rourke J, Yuan R, DeWille J. CCAAT/enhancer-binding protein-δ (C/EBP-δ) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 1997;272:6291-6.
26. 1 cell cycle arrest with induction of expression of p27 and activation of FKHR in CML blast cell. Abstract. Blood 2002;734a.
27. de Vos S, Hofmann WK, Grogan TM, et al. Gene expression profile of serial samples of transformed B-cell lymphomas. Lab Invest 2003;83:271-85.
28. Hofmann WK, de Vos S, Tsukasaki K, et al. Altered apoptosis pathways in mantle cell lymphoma detected by ollgonucleotide microarray. Blood 2001;98:787-94.
29. Ikezoe T, Miller CW, Kawano S, et al. Mutational analysis of the peroxisome proliferator-activated receptor γ gene In human malignancies. Cancer Res 2001;61: 5307-10.
30. Esquenet M, Swinnen JV, Heyns W, Verhoeven G. Control of LNCaP proliferation and differentiation: actions and interactions of andiogens, 1α,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate 1996:28:182-94.
31. Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 2003;80: 49-62.
32. 3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma. Cell Mol Endocrinol 2001;7: 1127-39.
33. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
34. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IκBα inhibits NF-κB activation. Mol Cell 1998;2:233-9.
35. Relaix F, Wei XJ, Wu X Sassoon DA. Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transaction pathway. Nat Genet 1998;18:287-91.
36. 3 analogue Involves the Induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 1997;19:15-27.
37. 3 In HL60 cells. Cancer Res 1996;56:264-7.
38. Pagano M. Cell cycle regulation by the ubiquitin pathway. FASEB J 1997;11:1067-75.
39. Hildebrandt H, Becker C, Gluer S, Rosner H. Gerardy-Schahn R, Rahmann H, Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. Cancer Res 1998;58:779-84.
40. Krishnan AV, Peehl DM, Feldman D. Inhibition of prostate cancer growth by vitamin D: regulation of target gene expression. J Cell Biochem 2003;88:363-71.
41. Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays. Prostate 2004;59:243-51.